Abstract
Background
This study was designed to establish a new diagnostic criteria of preoperative nodal status with high specificity on multidetector row computed tomography (MDCT) to extract advanced gastric cancer (GC) patients with an unfavorable prognosis.
Method
From total of 480 GC patients who underwent surgical resection, 58 consecutive patients with a preoperative diagnosis of nodal metastasis on MDCT were included in this retrospective study. Nodal status on MDCT was reassessed and a prognostic analysis was performed in the present study.
Results
Among several clinical nodal diagnostic criteria on MDCT, a cut-off value of the short-axis diameter measuring ≥15 mm showed the highest specificity (100 %). The prognostic analysis revealed that patients with nodal counts on MDCT of ≥3 (p = 0.035) as well as those with a nodal diameter ≥15 mm (p < 0.001) had a significantly poor prognosis. When patients with nodal counts ≥3 and at least one node that was ≥15 mm in diameter on MDCT were defined as having extensive lymph node metastasis (ELM) that had a significantly poor prognosis (5-year survival rates of 20 %, p < 0.001), and ELM was also an independent poor prognostic factor in advanced GC (p = 0.033, hazard ratio 4.038).
Conclusion
GC patients with nodal counts ≥3 and at least one node that was ≥15 mm in diameter on MDCT have extremely worse prognose with high diagnostic specificity. This novel surrogate indicator for preoperative imaging diagnosis may help personalized therapeutic strategies for GC patients with ELM.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Jansen EP, Boot H, Verheij M et al (2005) Optimal locoregional treatment in gastric cancer. J Clin Oncol 23:4509–4517
Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820
Bang YJ, Kim YW, Yang HK et al (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379:315–321
Kinoshita T, Sasako M, Sano T et al (2009) Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer 12:37–42
Yoshikawa T, Sasako M, Yamamoto S et al (2009) Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96:1015–1022
Inoue T, Yachida S, Usuki H et al (2012) Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. Ann Surg Oncol 19:2937–2945
Yoshikawa T, Tsuburaya A, Sano T et al (2011) Gastric cancer Surgical Study Group of Japan Clinical Oncology Group A phase II study of preoperative chemotherapy with S-1 (S) and cisplatin (P) followed by D3 gastrectomy for gastric cancer (GC) with extensive lymph node metastasis (ELM): survival results of JCOG0405. J Clin Oncol 29:2011(Suppl. 4)
Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660
Kawaguchi T, Ichikawa D, Komatsu S et al (2011) Clinical evaluation of JCGC and TNM staging on multidetector-row computed tomography in preoperative nodal staging of gastric cancer. Hepatogastroenterology 58:838–841
Kawaguchi T, Komatsu S, Ichikawa D et al (2012) Nodal counts on MDCT as a surrogate marker for surgical curability in gastric cancer. Ann Surg Oncol 19:2465–2470
Tokunaga M, Sugisawa N, Tanizawa Y et al (2013) The impact of preoperative lymph node size on long-term outcome following curative gastrectomy for gastric cancer. Ann Surg Oncol 20:1598–1603
Kwee RM (2009) Kwee TC Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 12:6–22
Shinohara T, Ohyama S, Yamaguchi T et al (2005) Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. Eur J Surg Oncol 31:743–748
Hasegawa S, Yoshikawa T, Shirai J et al (2013) A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT. Ann Surg Oncol 20:2016–2022
Morgagni P, Petrella E, Basile B et al (2012) Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread. World J Surg Oncol 10:197
Fukuya T, Honda H, Hayashi T et al (1995) Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 197:705–711
Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma 3rd English edition. Gastric Cancer 14:101–112
Makino M, Moriwaki S, Yonekawa M et al (1991) Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer. J Surg Oncol 47:12–16
Jaehne J, Meyer HJ, Maschek H et al (1992) Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg 127:290–294
Ichikura T, Tomimatsu S, Okusa Y et al (1993) Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 11:1894–1900
Roder JD, Bottcher K, Siewert JR et al (1993) Prognostic factors in gastric carcinoma. results of the German gastric carcinoma study 1992. Cancer 72:2089–2097
Adachi Y, Kamakura T, Mori M et al (1994) Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 81:414–416
Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20
Knight G, Earle CC, Cosby R et al (2013) Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer 16:28–40
Iwasaki Y, Sasako M, Yamamoto S et al (2013) Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 107:741–745
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawaguchi, T., Ichikawa, D., Komatsu, S. et al. Impact of Combination Criteria of Nodal Counts and Sizes on Preoperative MDCT in Advanced Gastric Cancer. World J Surg 40, 158–164 (2016). https://doi.org/10.1007/s00268-015-3007-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3007-7